Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
1 x
$
30.00
View Cart
Checkout
Home
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
“Paliperidone Double-blind, Placebo- and Active-Controlled, Study” has been added to your cart.
View cart
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
$
30.00
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 3 Articles
Tags:
antipsychotics
,
karen-l-hall
,
medworks-media
,
michael-r-ware
,
neuroleptic-malignant-syndrome
,
neuroleptics
,
olanzapine
,
psychopharmacology-bulletin
,
william-h-taylor
Description
Description
Karen L. Hall, MD
COMPLICATED CASE HISTORIES
Neuroleptic Malignant Syndrome Due to Olanzapine
Karen L. Hall, MD, William H.Taylor, MD, and Michael R.Ware, MD
Related products
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Page load link
Go to Top